Bank of America’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-29,358
| Closed | -$3K | – | 6708 |
|
|
2016
Q3 | $3K | Sell |
29,358
-1,308
| -4% | -$134 | ﹤0.01% | 5996 |
|
|
2016
Q2 | $11K | Buy |
30,666
+1,820
| +6% | +$653 | ﹤0.01% | 5661 |
|
|
2016
Q1 | $11K | Buy |
28,846
+436
| +2% | +$166 | ﹤0.01% | 5543 |
|
|
2015
Q4 | $11K | Sell |
28,410
-3,730
| -12% | -$1.44K | ﹤0.01% | 5652 |
|
|
2015
Q3 | $18K | Hold |
32,140
| – | – | ﹤0.01% | 5331 |
|
|
2015
Q2 | $17K | Buy |
32,140
+1,880
| +6% | +$994 | ﹤0.01% | 5382 |
|
|
2015
Q1 | $25K | Buy |
30,260
+14,600
| +93% | +$12.1K | ﹤0.01% | 4969 |
|
|
2014
Q4 | $13K | Hold |
15,660
| – | – | ﹤0.01% | 5345 |
|
|
2014
Q3 | $16K | Buy |
15,660
+5,130
| +49% | +$5.24K | ﹤0.01% | 5325 |
|
|
2014
Q2 | $9K | Buy |
+10,530
| New | +$9K | ﹤0.01% | 5632 |
|